We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Structural Study Shows Glucocorticoid Receptor Monomers Binding to DNA

By LabMedica International staff writers
Posted on 26 Dec 2012
A study based in large part on X-ray crystallography revealed that the transcription factor glucocorticoid receptor (GR) suppressed gene expression by binding to DNA in a previously unrecognized monomeric fashion.

In one of its many functions in the cell, GR—after binding a natural or synthetic glucocorticoid hormone—is transported from the cytoplasm to the nucleus where it binds to DNA and suppresses gene expression. More...


Investigators at Emory University (Atlanta, GA, USA) used X-ray crystallography and mechanistic approaches to study the suppressive binding of GR to DNA. They analyzed crystals comprising GR bound to a section of DNA called the thymic stromal lymphopoietin (TSLP) promoter.

Results reported in the December 9, 2012, online edition of the journal Nature Structural & Molecular Biology revealed that GR bound to TSLP in pairs, but with two monomeric GR molecules located on opposite sides of the DNA helix.

"This unexpected geometry was still a surprise because GR has never been crystallized as a monomer bound to DNA, though previous studies proposed that GR monomers repress genes as opposed to GR dimers, which activate genes," said senior author Dr. Eric Ortlund, assistant professor of biochemistry at Emory University.

Analysis of mutations that affect the ability of GR to bind repressive sites showed that binding of the first GR molecule inhibited the binding of a second GR molecule. This "negative cooperativity" may play a role in ensuring that only GR monomers bind to DNA. "Our structural data could help scientists design synthetic hormones that separate these two aspects of GR function, potentially leading to improved steroid hormones for diseases ranging from asthma to autoimmune disorders," said Dr. Ortlund.

Related Links:
Emory University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Prefilled Tubes
Prefilled 5.0ml Tubes
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.